Abstract
Expansion of a polyglutamine sequence in the N terminus of huntingtin is the gain-of-function event that causes Huntington's disease. This mutation affects primarily the medium-size spiny neurons of the striatum. Huntingtin is expressed in many neuronal and non-neuronal cell types, implying a more general function for the wild-type protein. Here we report that wild-type huntingtin acts by protecting CNS cells from a variety of apoptotic stimuli, including serum withdrawal, death receptors, and pro-apoptotic Bcl-2 homologs. This protection may take place at the level of caspase-9 activation. The full-length protein also modulates the toxicity of the poly-Q expansion. Cells expressing full-length mutant protein are susceptible to fewer death stimuli than cells expressing truncated mutant huntingtin.
Huntington's disease (HD) is an autosomal neurodegenerative disorder caused by a (CAG)n expansion in the gene IT15 (Huntington's disease Collaborative Research Group, 1993). This trinucleotide expansion encodes for a polyglutamine (QN) stretch in the encoded protein, huntingtin (Htt), resulting in progressive neuronal death with clinical symptoms of chorea and dementia (Ross et al., 1997). Studies on the cellular localization of the mRNA and protein have revealed that wild-type (wt) and mutated (mu) Htt are expressed throughout the nervous system as well as in non-neuronal cells (Sharp and Ross, 1996). Despite this widespread distribution, only specific neurons in the striatum and cortex are affected in HD (Vonsattel et al., 1985; Kowall et al., 1987). The cytotoxicity of the mu protein is believed to be caused by a gain-of-function effect induced by the presence of the expanded CAG (for review, see MacDonald and Gusella, 1996).
The molecular mechanism by which the poly-Q expansion triggers cell death is not understood (Reddy et al., 1999). Intracellular inclusions may be involved, but it is not clear whether they have a direct role in pathogenesis or are involved in progression (Davies et al., 1997; Di Figlia et al., 1997; Saudou et al., 1998) (for review, see Kim and Tanzi, 1998; Sisodia, 1998; Gutekunst et al., 1999; Hodgson et al., 1999). Proteolytic cleavage has been implicated by the findings of N-terminal fragments in inclusions and the fact that Htt is a caspase substrate and is actively cleaved during apoptosis in cultured cells (Goldberg et al., 1996; Davies et al., 1997; DiFiglia et al., 1997;Wellington et al., 1998; Kim et al., 1999). Experiments performed in primary striatal neurons showed that the poly-Q cytotoxicity can be inhibited by the anti-apoptotic protein Bcl-Xl and caspase inhibitors (Saudou et al., 1998). Involvement of caspases is also indicated by the observation that dominant negative caspase-1 delays disease progression in transgenic mice (Ona et al., 1999). Studies using an isolated poly-Q sequence have suggested that the first pathogenic event is the aggregation and activation of caspase-8 (Sanchez et al., 1999). Finally, activation of caspase-3 and caspase-9 was reported in HD lymphoblasts (Sawa et al., 1999).
Much less is known about the physiological roles of wtHtt. Mice with a targeted disruption of the Htt gene die at embryonic day 7.5 (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995). Moreover, analysis of mice expressing <50% of wtHtt showed extensive brain abnormalities and died shortly after birth (White et al., 1997). These data suggest that Htt is an important factor during embryonic development and that its role is not restricted to the nervous system.
To assess the function of wt and muHtt in neural cells, we developed a cell culture system composed of clonal striatal-derived cells overexpressing the wt or muHtt protein. We found that wtHtt has a role as a pro-survival molecule and acts upstream of caspase-3 and downstream of pro-apoptotic Bcl-2 proteins. We also found that toxicity of the poly-Q expansion is modulated by the length of Htt backbone.
MATERIALS AND METHODS
Constructs and transfections. FLwt [FL-23Q] and FLmu [FL-82Q] (Cooper, 1998), N548wt [nt1955–15] and N548mu [nt1955–128] (Hackam, 1998), myc-tagged N63wt [N63–18Q] and N63mu [N63–82Q] (Cooper, 1998) were subcloned into pLXSP vector or cotransfected with pLXSP as previously described (Cattaneo et al., 1996a). Briefly, ST14A cells were grown routinely at 33°C in the presence of DMEM supplemented with 10% fetal bovine serum as described (Cattaneo and Conti, 1998). Ten micrograms of cDNA were transfected using calcium phosphate or lipofectamine (Life Technologies) (Cattaneo et al., 1996b). Resistant clones were selected with puromycin 3 μg/ml, expanded, and cryopreserved. Transfection with the empty plasmid was also performed. For each construct, ∼20 colonies were isolated with cloning rings and analyzed.
Protein expression assay. Expression of the cDNAs was analyzed by Western Blot (WB) using antibody MAB2166 (dilution 1:2000; Chemicon, Temecula, CA), BKP1 (dilution 1:50), Ab1 (1 μg/ml, kindly provided by M. DiFiglia), and Ap194 (dilution 1:1000; kindly provided by A. Sharp). For N63wt and N63mu cDNAs immunoprecipitation with an anti-myc antibody (9E10, dilution 1:100; Calbiochem, La Jolla, CA) was performed after metabolic labeling of the cells. A total of 50 μg of proteins was loaded in each lane. To control for loading of the gels, an anti-actin antibody (Sigma, St. Louis, MO; 1:2000) was used. All assays were performed on cells that have been cultured up to the 25th passage.
Cell counting, MTT assay, and BrDU measurement. Cells were plated in triplicates into six well plates at a density of 2 × 105/well. After 8 hr incubation at 33°C the cultures were washed with HBSS, the medium was replaced with serum-deprived medium (SDM; composition: F-12/DMEM, 5 mg/l insulin, 100 mg/l transferrin, 20 nm progesterone, 30 nmselenite, 60 mm putrescine, 2 mm glutamine, 0.11 gm/l sodium pyruvate, 3.7 gm/l sodium bicarbonate, and 3.9 gm/l HEPES) and then incubated at 39°C. At the times indicated, cells were trypsinized, resuspended in 20 ml Isoton, and counted using a Coulter Counter machine (ZM; Coulter Instruments). For MTT assays, cells were exposed to 3-[4.5-dimethylthiazol-2-phenyl]-2.5-diphenyl-tetrazolium bromide, and release of formazan from mitochondria was quantified at 560 nm using an ELISA plate reader. 3-Nitro-propionic acid was obtained from Sigma.
For quantitation of the mitotic events, a 6 hr pulse of bromodeoxyuridine (BrDU; 10 μm, Sigma) was given to the cells (Cattaneo et al., 1994). At the end of incubation, cells were rinsed, fixed for 15 min in 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 for 5 min, and then incubated with anti-BrDU antibody (Becton Dickinson, Mountain View, CA; 1:50) (Magrassi et al., 1998).
Secondary FITC conjugated antibody to (Sigma) was used at 1:200. The cells were viewed with a Zeiss (Axiovert) microscope, and positive cells were scored manually.
DNA fragmentation and caspase activity. Cells were harvested in 10 mm Tris, pH 8, 20 mm EDTA, and 2% Triton X-100. Low molecular weight DNA was extracted by phenol/chloroform extractions and DNA precipitated with isopropanol. DNA fragmentation was detected on a 1% agarose gel.
Measurement of caspase-3 activity: samples of 1–2 × 106 cells were rinsed in cold PBS and lysed in a buffer containing 25 mm HEPES, pH 7.5, 5 mm EDTA, 1 mm EGTA, 5 mmMgCl2, 5 mm dithiothreitol, 1% 3-[-(3-cholamidopropyl)dimethylammonio]-1-propanesulfonicacid (CHAPS), 10 μg/ml pepstatin and leupeptin, and 1 mm PMSF. The cell lysates were centrifuged (for 3 min at 5000 rpm), and the supernatants stored at −80°C. Lysates were incubated at 37°C in a buffer containing 25 mm HEPES, pH 7.5, 10% sucrose, 0.1% CHAPS, and 1 mm DTT supplemented with Ac-DEVD-7-amino-4-methylcoumarin (amc) (50 μm). The increase of fluorescence after the cleavage of the fluorogenic amc moiety was monitored and then quantified in a LS50 Perkin-Elmer (Emeryville, CA) fluorimeter (excitation, 380 nm; emission, 460 nm). Protein content was assayed by the bicinchoninic acid procedure. For quantitation, standard curves using increasing concentrations of amc moiety were performed in parallel.
Constitutively active caspase-3 (Srinivasula et al., 1998) or pLXSP plasmid (as a control) were cotransfected with the EGFP-N1 plasmid (Clontech, Palo Alto, CA) in the ratio 10:1. Cell viability was determined 30 hr after transfection by counting the ratio of green-stained cells (EGFP-positive) versus total number of cells.
TUNEL assay. 2–3 × 105cells were transfected with 250 ng of pCMV-EGFP and 1 μg of the indicated plasmids (0.4 μg for Bik and Bak). Expression from the transiently transfected genes was confirmed by WB and found to range between 10 and 15 times above control. After 24 hr the cells and their supernatant were harvested, and terminal transferase terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) was essentially performed as described previously, using phycoerythrin (PE)-conjugated avidin (Gorczyca et al., 1993). Stained cells were analyzed by dual color FACS, collecting at least 10,000 events. The number of TUNEL-positive cells was estimated by gating on the EGFP-expressing cells, excluding ≥95% of untransfected cells. Transfection efficiencies were ∼30–40%. The PE gate was set using vector-only transfected cells, excluding ≥95% of unstained cells. Background death was introduced by the transfection procedure and varied between individual experiments, but was constant within any given experiment. Therefore, background death was estimated by transfection of control protein 14-3-3 and subsequently subtracted from the data.
Statistical analysis. Data reported in Figures 3, 4, and 6and in Results were compared using the one-way ANOVA test (ap value < 0.05 was considered significant). Statistical analysis for data reported in Figure 7 is nonparametric, and SD derives from data obtained in three different experiments.
RESULTS
Expression of wt and muHtt in ST14A striatal cells
Conditionally immortalized ST14A cells were stably transfected with full-length wt or poly-Q expanded Htt constructs (FLwt and FLmu, respectively) or with the Htt truncations (N548wt, N548mu, N63wt, and N63mu), as outlined in Figure1A.
Expression of the exogenous proteins in the different subclones was confirmed by Western blot analysis (Fig. 1B) and immunocytochemistry (data not shown) using antibody MAB2166 raised against aa 181–810 of the Htt protein. As shown, a band of 340 kDa is visible on a 6% SDS-PAGE in the FLwt and FLmu clones. Similarly, a 72 kDa band is present in N548wt clones, whereas N548mu shows a 115 kDa band. This decreased electrophoretic mobility is attributable to the expanded CAG. Identical results were obtained with Ab1, BKP1, and AP194 antibodies (data not shown). Because the N63 constructs are myc-tagged, their expression was confirmed by an anti-myc antibody (Fig.1B).
Size and stability of the exogenously expressed proteins over time was confirmed on lysates obtained from cells at the 4th, 12th and 25th passages. A representative Western blot performed on lysates from N548wt and N548mu cells is shown in Figure 1C. As visible, the intensity of the immunoreactive band in cells bearing the wild-type or mutated protein did not decline with time in vitro, up to the 25th passage. In addition, the size of the immunoreactive band remained the same, indicating that the poly-Q repeat is stably replicated in ST14A cells.
Wt and muHtt differentially affect cell viability
ST14A cells were derived from the embryonic striatum via retroviral transduction of the temperature-sensitive version of the Large-T Antigen (Cattaneo et al., 1994; Cattaneo and Conti, 1998). ST14A cells grow in 10% serum at the permissive temperature of 33°C (Fig. 2a) with a doubling time of 36 hr (Cattaneo et al., 1996a). Shifting to the nonpermissive temperature of 39°C leads to degradation of the Large-T Antigen, with consequent block of cell proliferation and reversal of the phenotype back to that of a differentiating neuroblast. This was better demonstrated in in vivo transplantation studies (Cattaneo et al., 1994; Lundberg et al., 1997; Benedetti et al., 2000). When ST14A cells were exposed in vitro to 39°C in serum-deprived medium (SDM), cells changed morphology but also their viability decreased with time in a highly reproducible manner (Fig.2b). In these conditions, increased cell death was observed in cells expressing the N548mu construct (Fig. 2d). In sharp contrast, cells overexpressing the N548wt cDNA remained viable in the same culturing conditions (Fig. 2f).
Quantitations of these effects by Coulter Counter (Fig.3a,b) and MTT (which measures cell viability and/or mitochondrial activity; Fig. 3c,d) assays confirmed that all clones behaved approximately the same in normal growth conditions (Fig. 3a,c). However, when challenged by serum deprivation at 39°C, significant differences in cell viability and mitochondrial activity were measured (Fig.3b,d). ST14A cells (open squares) show, in both assays, the typical decrease in cell viability. This effect was more rapid in N548mu cells (open circles). Remarkably however, when N548wt was overexpressed (open diamonds), cell viability was maintained even at 72 hr, and decreased only at longer time points (96 hr). Analysis of protein levels at these later time points at 39°C revealed that the decrease in cell viability correlated with a reduction in the level of the exogenous protein (data not shown), further confirming the relationship between expression of wtHtt and the phenotype observed. This correlation was further substantiated by the finding that subclones that did not express the exogenous proteins behaved as parental ST14A cells.
To exclude the possibility that increased cell number in the presence of N548wt was caused by cell proliferation, a 6 hr BrDU pulse was given to cells exposed to 39°C for 48 or 72 hr. We found that parental, wt, and muHtt-expressing cells divided with the same rate at 33°C but, no division was detected at 39°C in all clones, including N548wt cells (data not shown). As expected, all clones were also negative for the Large-T Antigen at 39°C (data not shown). These data indicate that N548wt acts by increasing cell survival and not cell division.
The pro-survival effect of wtHtt was observed in cells bearing the N548wt construct. Analogously, expression of FLwt under the same conditions produced a similar protective effect (Fig. 3d, asterisk). In contrast, cells expressing a shorter N63 cDNA in the wt form (Fig. 3d, filled diamond) were not protected and showed the same profile as parental cells. These data indicate that the protective effect of wtHtt requires a segment of the protein between aa63 and aa548.
Finally, exposure of the cells to another stress stimulus, 3-nitropropionic acid (3-NP), an inhibitor of complex I activity, revealed a similar protective effect in N548wt and FLwt cells compared to parental ST14A cells. Figure 4 shows that cultures of parental ST14A cells exhibited a dose-dependent decrease in cell viability and/or mitochondrial activity by MTT assay after 1 and 5 mm 3-NP. This decrease was more evident in N548mu cells. However, cells from a representative clone expressing N548wt were almost completely protected by the action of the toxin. The same was observed in other two N548wt clones (data not shown) and in cells bearing the FLwt protein (Fig. 4). We concluded that wtHtt can protect from mitochondrial toxins.
MuHtt induces, whereas wtHtt prevents, apoptotic cell death
To determine if the cell death observed in the presence of N548mu is attributable to apoptosis and if N548wt (and FLwt) prevented DNA fragmentation, we performed the temperature shift experiment, followed by DNA analysis or Hoechst staining. As visible in Figure5A, ST14A cells showed DNA laddering at 20 hr after the shift. Consistent with the above data, the appearance of the laddering occurred in N548mu at 1 and 4 hr after the shift. Remarkably however, cells expressing the N548wt showed no DNA laddering even at 20 hr after the shift. Similarly, Figure5B shows that cultures of cells expressing N548mu (d) present an higher percentage of nuclei with condensed DNA with respect to parental ST14A cells. This phenomenon was not observed in N548wt cells (f). These results together indicate that wtHtt directly influences cell survival and acts as an anti-apoptotic protein in neural cells.
The data reported so far also indicate that N548mu exacerbates apoptotic cell death in ST14A cells. As discussed later, however, Flmu cells behave differently from N548mu cells.
WtHtt prevents caspase-3 activation by acting at the level of caspase-9
In search of the molecular target of wtHtt action, we first analyzed whether wtHtt affected the activity of the caspase cascade. We therefore examined the effect of the temperature shift on the activity of the effector caspase-3. Figure6A shows caspase-3-like activity measured by monitoring the release of the fluorogenic amc moiety from the caspase-3-specific substrate Ac-DEVD-amc. As shown, parental ST14A cells have a low basal level of caspase-3-like activity in normal growth conditions. Exposure of the cells to SDM at 39°C led to an increase in activity, in good agreement with the tendency of ST14A cells to undergo apoptotic cell death in these conditions. Under the same conditions, a twofold to fivefold greater activity was measured in N548mu cells. Most significant, the N548wt-expressing cells had a lower level of caspase-3-like activity than in the parental line throughout the duration of the experiment (Fig. 6A), in agreement with the observations presented above. Similar results were obtained with two other clones expressing N548wt or with the clones expressing FLwt Htt. These data indicate that wtHtt acts by inhibiting caspase-3-like activation. To further demonstrate this point, parental ST14A and cells bearing N548wt or FLwt Htt were transiently cotransfected with a constitutively active caspase-3 construct and the EGFP plasmid. As shown in Figure6B, transfection of active caspase-3 kills all cells efficiently independent of upstream signaling and, according to our data, after the site where wtHtt exerts its protective effect.
These data confirm that wtHtt acts upstream of caspase-3 activation.
In an attempt to deliver more defined death stimuli and better identify the site of action of wtHtt, we next transfected the cells with various pro-apoptotic genes (Fig. 7). We found that cells expressing wtHtt were completely protected from death induced by p55/TNFRI death receptor as well as by the pro-apoptotic Bcl-2 family members, BIK and BAK. Even after transfection of the apical caspase-9, the number of TUNEL-positive cells was reduced in wtHtt-expressing cells.
These data indicate that wtHtt acts upstream of caspase-3 and possibly at the level of caspase-9 activation.
The caspase-3 zymogen and BclXL–Bcl2-associated death promoter synergize with the mutation
Interestingly, whereas transfection of most death inducers had similar effects in parental ST14A, N548mu, or Flmu cells, transfection of the zymogen (inactive) form of caspase-3 killed the mutant expressing cells efficiently (Fig. 7). The same construct was inefficient in parental or wtHtt-expressing cells (Fig. 7), reflecting the tight control normally exerted on caspase-3 cleavage in these and other cells (Srinivasula et al., 1998). We concluded that expression of the poly-Q expanded protein conferred caspase-3 processing ability selectively in N548mu and Flmu cells. Finally, Figure 7 also shows that expression of BclXL–Bcl2-associated death promoter (BAD) produced an increase in TUNEL-positive cells only in clones expressing muHtt constructs. This indicates that muHtt toxicity feeds into a pathway that requires BAD or a BAD-like function and argues against a direct activation of caspase-3.
Flmu cells are killed by fewer stimuli compared to N548mu cells
Of note and surprisingly, whereas FLmu and N548mu cells were both as efficiently killed by caspase-3 or BAD transfection, FLmu cells were found to be resistant to other stress stimuli. For example, in contrast to N548mu cells (Fig. 3), exposure of FLmu cells for various periods of time to SDM at 39°C did not evoke increased cell demise compared to parental cells (absorbance ratio at various time points after exposure to SDM at 39°C with respect to T0 hr, parental ST14A cells: T2 hr100 ± 7.4; T32 hr82.3 ± 3.3; T48 hr = 48.0 ± 1.8; Flmu cells, 10–6 clone: T2 hr= 100 ± 7.3; T32 hr = 100.3 ± 11.7; T48 hr = 58.1 ± 6.1; Flmu cells, 10–11 clone: T2 hr = 100 ± 11.2; T32 hr = 84.9 ± 1.9; T48 hr = 57.7 ± 0.8).
Similarly, 3-NP exposure produced a decrease in cell viability and/or mitochondrial activity in N548mu cells (Fig. 4) but was inefficient in Flmu cells (absorbance ratio in the presence of 3-NP compared to untreated cultures, parental ST14A cells: 1 mm = 77.1 ± 7.3; 5 mm = 63.1 ± 4.2; Flmu cells, 10–6 clone: 1 mm = 83.5 ± 6.6; 5 mm = 65.8 ± 4.9; Flmu cells, 10–11 clone: 1 mm = 72.4 ± 7.0; 5 mm = 51.9 ± 2.7). These data suggest that expression of a CAG as part of the FL protein modifies its toxicity. Accordingly, cells expressing the full-length protein are susceptible to fewer death stimuli compared to cells expressing truncated versions of the mutated protein.
DISCUSSION
HD is caused by an expanded poly(Q) in Htt, a protein of 340 kDa molecular weight with cytoplasmic location, and no functional domains that was found to be crucial during embryonic development. Htt is widely distributed in the CNS, however it is unlikely that Htt plays a specific role in neuronal differentiation because Htt−/− embryonic stem cells turn into mature neurons in vitro in the same way as the wild-type counterparts (Metzler et al., 1999).
To address the question of the exact physiological role of wtHtt in CNS cells and whether and how it relates to muHtt action, we have obtained striatal derived cells stably expressing a wt or mu poly(Q) stretch in the context of the full-length Htt protein or in the N-terminal 548aa or 63aa truncations. We show that, in this cellular system, wtHtt acts as a pro-survival molecule. This effect is observed only when full-length protein or the N548 Htt truncation is expressed. Further deletion of the protein to an N-terminal 63aa fragment resulted in the loss of the pro-survival effect. These data indicate that the protective effect of wtHtt requires at least a segment of the protein between aa63 and aa548.
Previous work demonstrated that homozygous mice with a targeted disruption in the Htt gene do not survive to term and suffer early postimplantation embryonic lethality (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995; White et al., 1997). More recent morphometric and ultrastructural analysis performed on heterozygous mice, which survive to adulthood, identified neuronal loss with signs of apoptosis in the basal ganglia of adult animals (O'Kusky et al., 1999). In our system, we found that wtHtt specifically interferes with the cell death machinery. Serum withdrawal and exposure to mitochondrial toxins led to apoptotic death in parental cells. Mu Htt-expressing cells were sensitized to these apoptotic stimuli. In contrast, these stimuli were ineffective in cells expressing wtHtt. The data indicate that wtHtt directly influences cell survival by acting as an anti-apoptotic protein. Htt is also an important survival factor earlier in development because its absence evokes increased apoptosis in the epiblast, a structure of the embryo known to give rise to the future ectoderm (Duyao et al., 1995).
To delineate the mechanism of wtHtt anti-apoptotic function, we transiently expressed several pro-apoptotic genes in the different ST14A subclones. We found that cells expressing wtHtt were protected from cell death induced by death receptors, by the pro-apoptotic Bcl-2 family members (Bik and Bak), as well as by caspase-9. This protection from multiple apoptotic inducers implies that wtHtt acts on components of the common death effector pathway. Furthermore, the protection from pro-apoptotic Bcl-2 homologs implies that wtHtt is acting on mitochondrial or postmitochondrial apoptotic events. Once caspase-9 is activated by the apaptosome complex consisting of Apaf-1 and cytochrome C (Cecconi et al., 1998; Yoshida et al., 1998), it directly activates the downstream protease, caspase-3 (Zou et al., 1999). The protection from apoptosis induced by caspase-9 transfection (Fig. 7) combined with the reduced activity of its downstream effector, caspase-3, in wtHtt cells (Fig. 6A) and to the evidence that the same cells could be killed by transfection of a constitutively active form of caspase-3 (Fig. 6B) leads us to suggest that wtHtt acts upstream of caspase-3 and likely at the level of caspase-9 activation.
A poly (Q) expansion in the Htt gene is suggested to produce a toxic gain-of-function effect. Accordingly, expression of muHtt induces cell death in transgenic animals and in cell culture systems (Cooper et al., 1998; Hackam et al., 1998; Lunkes and Mandel, 1998; Reddy et al., 1998;Hodgson et al., 1999). Striatal-derived ST14A cells overexpressing muHtt undergo a similar fate when challenged with various stress stimuli (serum withdrawal, 3-NP exposure). In our system we found that, in the presence of muHtt, DNA fragmentation is accompanied by an increased caspase-3-like activation, which is consistently above the level found in parental ST14A cells. These data suggest that the toxic effect of muHtt converges onto caspase-3. As a further demonstration, we transfected the zymogen form of caspase-3, which normally does not lead to apoptosis (Srinivasula et al., 1998), into muHtt expressing cells and found an increase in the number of TUNEL-positive cells. Increased activation of caspase-3 and caspase-9 was also recently reported in lymphoblasts from Huntington's disease patients exposed to chemical inducers of apoptosis (Sawa et al., 1999). Interestingly, comparisons of the phenotypes of cells expressing different muHtt constructs reveal that the toxicity of the polyglutamine repeat is modulated by the protein backbone. Indeed we found that FLmu protein promotes cell death only by selective stimuli (BAD or caspase-3 transfections), whereas N548mu truncation promotes death by a larger range of death stimuli (BAD or caspase-3 transfections, 3-NP exposure, serum withdrawal). These results highlight the possibility that truncated versions of poly(Q) proteins induce a wider spectrum of cytotoxic events than the full-length proteins and support the notion that proteolytic cleavage is important in HD.
Further analysis of the roles and mechanisms of action of wtHtt will help to better understand its physiological functions and whether and how the poly(Q) expansion in the mutated protein interferes with those and/or other activities.
Footnotes
This work was supported by the Huntington's Disease Society of America (HDSA), the Hereditary Disease Foundation (HDF), Telethon (Italy #E840), and Consiglio Nazionale delle Ricerche (Italy, #98.01050.CT04) to E.C., National Institutes of Health Grants ROI E50811 and DAMD 17-96-1-6085 to C.V., and National Institutes of Health Grant NS16375 to C.A.R. The support of the Istituto Bancario San Paolo di Torino (Agenzia 8, Milano) to E.C. is also acknowledged. A special thanks to the members of the HDSA and HDF for their constant and strong encouragement and to the Associazione Italiana Corea di Huntington (AICH) for their interest in our work. We thank Drs. Michelle Ehrlich and Samgram Sisodia for critical discussion and comments on this manuscript. We also thank Dr. Alnemri E. for providing the active caspase-3 construct, Mara Monetti for help with cell culture work, and Ann-Marie DesLaurier for help with the FACS analysis. E.C., M.R.H., and C.A.R. are members of the “Coalition for the Cure” (HDSA). E.C. is also a member of the “Cure Initiative” (HDF).
D. R. and J. B. contributed equally to this work.
Correspondence should be addressed to Dr. Elena Cattaneo, Institute of Pharmacological Sciences, University of Milano, Via Balzaretti 9, 20133 Milano, Italy. E-mail: elena.cattaneo{at}unimi.it.